跳至主要内容
临床试验/ISRCTN16794957
ISRCTN16794957已完成未知

Determining feasibility of Randomisation to high vs. ad libitum water Intake in Polycystic Kidney Disease: the DRINK randomised feasibility trial

Cambridge University Hospitals NHS Foundation Trust and University of Cambridge0 个研究点目标入组 50 人开始时间: 2016年11月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

2018 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/29743334 (added 20/05/2019)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Have given written informed consent to participate
  • 2. Aged 16 years or older
  • 3. Have a diagnosis of ADPKD (fulfilling radiological diagnostic criteria ± genetic evidence)
  • 4. eGFR = 20ml/min/1.73m2
  • 5. Able to self-monitor urine SG

排除标准

  • 1. Inability to provide informed consent
  • 2. eGFR < 20ml/min
  • 3. Fluid overload states e.g. heart failure, cirrhosis, or requirement for fluid restriction
  • 4. Confounding illness impacting on renal disease e.g. concomitant diabetes or glomerulonephritis
  • 5. Treatment with diuretics for fluid overload (those on diuretics for hypertension may participate in the trial after a run-in period of 2 weeks)
  • 6. Treatment with Tolvaptan in the last 4 weeks
  • 7. Pregnancy or breastfeeding

研究者

发起方
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge

相似试验